DOH ‘pauses’ use of Johnson & Johnson vaccine

The state Department of Health said today it will pause its use of the Johnson & Johnson COVID-19 vaccine.

The U.S. on Tuesday recommended a “pause” in using the single-dose vaccine to investigate reports of rare but potentially dangerous blood clots, the Associated Press reported.

Centers for Disease Control and Prevention and the Food and Drug Administration announced that they were investigating unusual clots in six women between the ages of 18 and 48. One person died.

The clots, which happened 6 to 13 days after vaccination in veins that drain blood from the brain, occurred together with low platelets, the fragments in blood that normally form clots, the AP reported. More than 6.8 million doses of the J&J vaccine have been given in the U.S., the vast majority with no or mild side effects.

According to an update on, vaccination clinics in Hawaii that were scheduled to administer the single-shot vaccine may offer the Moderna vaccine or reschedule today.


Leave a Reply

Your email address will not be published. Required fields are marked *


By participating in online discussions you acknowledge that you have agreed to the Star-Advertiser's TERMS OF SERVICE. An insightful discussion of ideas and viewpoints is encouraged, but comments must be civil and in good taste, with no personal attacks. If your comments are inappropriate, you may be banned from posting. To report comments that you believe do not follow our guidelines, email